Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative...
Nature Communications - The heterogeneity of tumor evolution from AR-positive, adenocarcinoma to AR-negative, neuroendocrine prostate cancer (NEPC) is not fully characterized. Here the authors...
nature.com